Entry |
|
Name |
Rivoglitazone (USAN/INN) |
Formula |
C20H19N3O4S
|
Exact mass |
397.1096
|
Mol weight |
397.45
|
Structure |
|
Class |
|
Efficacy |
Antidiabetic, Peroxisome proliferator-activated receptor (PPAR) gamma agonist |
Comment |
Thiazolidinedione derivative
Treatment of type II diabetes mellitus
|
Target |
|
Pathway |
|
Interaction |
|
Structure map |
map07222 | Peroxisome proliferator-activated receptor (PPAR) agonists |
|
Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01683 Thiazolidinedione
D05739 Rivoglitazone
DG02044 Hypoglycemic agent
DG01683 Thiazolidinedione
D05739 Rivoglitazone
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Peroxisome proliferator-activated receptor (PPAR)
NR1C3 (PPARG)
D05739 Rivoglitazone (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 28
1 C8x C 28.2800 -12.8100
2 C8y C 28.2800 -14.2100
3 C8x C 29.4700 -14.9100
4 C8x C 30.7300 -14.2100
5 C8y C 30.7300 -12.8100
6 C8x C 29.4700 -12.1100
7 C1b C 31.9200 -12.1100
8 C1y C 33.1100 -12.8100
9 C5x C 33.1100 -14.2100
10 N1x N 34.4400 -14.7000
11 C5x C 35.2800 -13.5100
12 S2x S 34.5100 -12.3900
13 O5x O 36.6800 -13.5100
14 O5x O 31.9900 -15.0500
15 O2a O 27.0900 -14.9100
16 C1b C 27.0900 -16.3100
17 C8y C 25.9000 -17.0100
18 C8y C 21.3500 -16.3100
19 C8x C 21.3500 -17.7100
20 C8x C 22.5400 -18.4100
21 C8y C 23.8000 -17.7100
22 C8y C 23.8000 -16.3100
23 C8x C 22.5400 -15.6100
24 N5x N 25.1300 -18.1300
25 N4y N 25.1300 -15.8900
26 C1a C 25.5854 -14.5661
27 O2a O 20.1347 -15.6149
28 C1a C 18.9463 -16.3077
BOND 31
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 8 12 1
14 11 13 2
15 9 14 2
16 2 15 1
17 15 16 1
18 16 17 1
19 18 19 2
20 19 20 1
21 20 21 2
22 21 22 1
23 22 23 2
24 18 23 1
25 21 24 1
26 24 17 2
27 17 25 1
28 22 25 1
29 25 26 1
30 18 27 1
31 27 28 1
|